Pulmonary Arterial Hypertension Treatment Market Is Expected to Register at 2.5% CAGR by 2028
Endothelin Receptor Antagonists (ERAs) to lead the Market among Drugs; SGC Stimulators to Capture Market by the End of 2028 Owing to Drug Effectiveness
View full press release